Concepedia

David H. Lynch

DH

Statistics

Publications

100

Citations

17.8K

H-Index

59

Active since

1978

Affiliations

Research & Development Corporation(Current)

IDEX Corporation (United States)

University of Utah

Mayo Clinic

Amgen (United States)

David H. Lynch is an author at Research & Development Corporation specializing in life sciences, immunology, and apoptosis.

ORCID

Publications per year

1978–2025

100

Publications

100

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

Henning Walczak, Robert E. Miller, K. Ariail et al. · Nature Medicine · 1999 · 2.5K citations

, , +12

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas

Thomas Brunner, R J Mogil, Drake LaFace et al. · Nature · 1995 · 1.3K citations · Full text

, , +15

Induction of apoptosis in mature T cells by tumour necrosis factor

Lixin Zheng, Galen H. Fisher, Robert E. Miller et al. · Nature · 1995 · 1.1K citations

, , +14

Fas ligand mediates activation-induced cell death in human T lymphocytes.

Mark R. Alderson, Teresa W. Tough, Terri Davis‐Smith et al. · The Journal of Experimental Medicine · 1995 · 949 citations · Full text

, , +17

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells

Hilary J. McKenna, Kim L. Stocking, Robert E. Miller et al. · Blood · 2000 · 882 citations

, , +16

1–5 of 100